Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roger Perlmutter
Biotech
Eikon cuts staff to 'become more efficient,' CEO says
Eikon Therapeutics, a biotech that has raked in some of the largest financing rounds in recent memory, has cut staff to “become more efficient.”
Annalee Armstrong
,
Max Bayer
Oct 7, 2023 6:36pm
Eikon snaps up clinical pipeline thanks to 'buyer's market'
Jun 1, 2023 8:00am
Reuniting the band: Former Merck CEO follows colleagues to Eikon
Mar 31, 2022 10:13am
Merck's CMO follows Roger Perlmutter to Eikon
Mar 23, 2022 11:38am
Perlmutter named CEO of biotech pursuing undruggable targets
May 5, 2021 6:30am
7-year itch: Perlmutter exits as Merck R&D lead
Oct 2, 2020 8:30am
